CWC
BIIB icon

Carolinas Wealth Consulting’s Biogen BIIB Stock Holding History

Carolinas Wealth Consulting’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12
Closed -$1.84K – 1023
2024
Q4 		$1.84K Buy
12
+10
+500% +$1.69K ﹤0.01% 843
2024
Q3 		$388 Sell
2
-3
-60% -$628 ﹤0.01% 1022
2024
Q2 		$1.16K Hold
5
– – ﹤0.01% 886
2024
Q1 		$1.08K Sell
5
-51
-91% -$11.9K ﹤0.01% 884
2023
Q4 		$14.5K Hold
56
– – ﹤0.01% 492
2023
Q3 		$13.3K Hold
56
– – ﹤0.01% 486
2023
Q2 		$16K Hold
56
– – ﹤0.01% 515
2023
Q1 		$15.6K Sell
56
-15
-21% -$4.15K ﹤0.01% 533
2022
Q4 		$19.7K Sell
71
-6
-8% -$1.7K ﹤0.01% 499
2022
Q3 		$21K Hold
77
– – 0.01% 436
2022
Q2 		$16K Sell
77
-10
-11% -$2.04K ﹤0.01% 489
2022
Q1 		$18K Sell
87
-20
-19% -$4.35K ﹤0.01% 500
2021
Q4 		$26K Buy
107
+2
+2% +$514 0.01% 441
2021
Q3 		$30K Buy
105
+7
+7% +$2.29K 0.01% 411
2021
Q2 		$34K Buy
98
+10
+11% +$3.03K 0.01% 414
2021
Q1 		$25K Sell
88
-52
-37% -$14K 0.01% 472
2020
Q4 		$34K Buy
140
+87
+164% +$22.4K 0.01% 394
2020
Q3 		$15K Buy
53
+49
+1,225% +$13.7K 0.01% 424
2020
Q2 		$1K Buy
+4
New +$1.2K ﹤0.01% 542

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Carolinas Wealth Consulting's BIIB Position: Q1 2025 in Review

Carolinas Wealth Consulting sold out of Biogen (BIIB) in Q1 2025, closing a stake of 12 shares — an estimated $1.84K sold.

Carolinas Wealth Consulting first reported a position in BIIB in Q2 2020 and held it in 19 quarters. The position peaked at $34K in Q2 2021. 881 funds tracked by Wall St. Rank hold BIIB as of Q1 2025.

  • Carolinas Wealth Consulting reported no remaining Biogen position as of Q1 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 12 Biogen shares in Q1 2025, an estimated $1.84K.
  • Carolinas Wealth Consulting first reported a position in Biogen in Q2 2020 and held it in 19 quarters.
  • Carolinas Wealth Consulting's Biogen position peaked at $34K in Q2 2021.
  • 881 funds tracked by Wall St. Rank held Biogen as of Q1 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q1 2025, filed 14 Aug 2025.